When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Eszopiclone - Wikipedia

   en.wikipedia.org/wiki/Eszopiclone

   Eszopiclone, sold under the brand name Lunesta among others, is a medication used in the treatment of insomnia. [ 3 ] [ 4 ] Evidence supports slight to moderate benefit up to six months. [ 5 ] [ 4 ] [ 6 ] It is taken by mouth .

3. Steroid dementia syndrome - Wikipedia

   en.wikipedia.org/wiki/Steroid_dementia_syndrome

   Sacks et al. (2005) reported the case of a 72-year-old man, described as professionally successful, intelligent, and cultivated, with polymyalgia rheumatica, who after being treated with prednisone developed a psychosis and dementia, which several behavioral neurology and neuropsychiatry consultants initially diagnosed as early dementia or ...

4. Zopiclone - Wikipedia

   en.wikipedia.org/wiki/Zopiclone

   It works by causing a depression or tranquilization of the central nervous system. After prolonged use, the body can become accustomed to the effects of zopiclone. When the dose is then reduced or the drug is abruptly stopped, withdrawal symptoms may result. These can include a range of symptoms similar to those of benzodiazepine withdrawal.

5. This Surprising Factor Could Increase Your Dementia Risk by ...

   www.aol.com/lifestyle/meaningful-relationships...

   Dementia and brain disorders are getting a lot of attention these days. And for good reason. About 1 in 10 Americans over 65 have dementia. And it’s estimated that the number of people 65 and ...

6. Doctors Say This Common Injury Could Be a Dementia ... - AOL

   www.aol.com/lifestyle/doctors-common-injury...

   Dementia is a devastating disease that impacts one in 10 older Americans. But while many people want to avoid developing dementia, the exact causes of the condition have remained largely a mystery ...

7. Type 2 diabetes drugs could lower dementia, Parkinson's ... - AOL

   www.aol.com/type-2-drugs-could-lower-133000670.html

   The analysis showed that over a follow-up period of an average of 2.06 years for people on SGLT2 inhibitors, and 3.70 years for people on different antidiabetes drugs, there was a reduction in the ...